Skip to Content

Tenet Healthcare Corp THC

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Raising Tenet's Fair Value Estimate After 3Q Blows Away Expectations

Julie Utterback, CFA Senior Equity Analyst

Analyst Note

| Julie Utterback, CFA |

Tenet turned in stellar third-quarter operating results that allowed management to raise its guidance for the third time this year and put it on track to beat our expectations for 2021. After raising our operating expectations moderately, we also raised our fair value estimate to $60 per share from $55 previously. Although shares continue to trade above our fair value, our very high uncertainty rating highlights the large margin of safety that we would require to make a transaction, including on the upside. For example, if the firm continues to operate at these impressive levels, including ROICs well over WACC after recent capital allocation activities like pruning underperforming assets, acquiring high-margin ambulatory surgery centers, and reducing debt on its balance sheet; we would consider raising Tenet's current no moat rating, which could also have a valuation impact all else being equal.

Read Full Analysis

Company Profile

Business Description

Tenet Healthcare is a Dallas-based healthcare provider organization operating a collection of hospitals (60 as of September 2021) and over 550 outpatient facilities, including ambulatory surgery centers, urgent care centers, freestanding imaging centers, freestanding emergency rooms/micro-hospitals, and physician practices across the United States. Tenet enjoys the number-one ambulatory surgical center position nationwide, as well.

14201 Dallas Parkway, Suite 1400
Dallas, TX, 75254
T +1 469 893-2200
Sector Healthcare
Industry Medical Care Facilities
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 31, 2020
Stock Type Slow Growth
Employees 110,000